New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

Serge Saxonov Biography and Net Worth

CEO of 10x Genomics

Serge Saxonov co-founded 10x Genomics in 2012. As the CEO, he defined the 10x vision and strategy, contributed to core inventions, and has led the company since inception. Prior to 10x Genomics, Serge was Vice President of Applications at QuantaLife, where he built products and defined the company’s growth areas. Serge was the first employee at 23andMe, where he served as Founding Architect and Director of R&D. There he defined the initial concept of the product, built out the core technology, and drove strategy and execution of R&D functions. Serge received a Ph.D. in biomedical informatics from Stanford University and an A.B. in applied mathematics from Harvard College.

What is Serge Saxonov's net worth?: The estimated net worth of Serge Saxonov is at least $41.57 million as of November 22nd, 2023. Dr. Saxonov owns 851,169 shares of 10x Genomics stock worth more than $41,571,094 as of December 10th. This net worth approximation does not reflect any other assets that Dr. Saxonov may own. Additionally, Dr. Saxonov receives a salary of $837,680.00 as CEO at 10x Genomics. Learn More about Serge Saxonov's net worth.
How old is Serge Saxonov?: Dr. Saxonov is currently 46 years old. There are 4 older executives and no younger executives at 10x Genomics. Learn More on Serge Saxonov's age.
What is Serge Saxonov's salary?: As the CEO of 10x Genomics, Inc., Dr. Saxonov earns $837,680.00 per year. Learn More on Serge Saxonov's salary.
How do I contact Serge Saxonov?: The corporate mailing address for Dr. Saxonov and other 10x Genomics executives is 6230 STONERIDGE MALL ROAD, PLEASANTON CA, 94588. 10x Genomics can also be reached via phone at 925-401-7300 and via email at [email protected]. Learn More on Serge Saxonov's contact information.
Has Serge Saxonov been buying or selling shares of 10x Genomics?: Within the last three months, Serge Saxonov has sold $326,427.44 in 10x Genomics stock. Most recently, Serge Saxonov sold 3,723 shares of the business's stock in a transaction on Friday, November 24th. The shares were sold at an average price of $43.72, for a transaction totalling $162,769.56. Following the completion of the sale, the chief executive officer now directly owns 847,446 shares of the company's stock, valued at $37,050,339.12. Learn More on Serge Saxonov's trading history.
Who are 10x Genomics' active insiders?: 10x Genomics' insider roster includes Bradford Crutchfield (Insider), Benjamin Hindson (Insider), Sridhar Kosaraju (Director), Mathai Mammen (Director), Justin McAnear (CFO), Serge Saxonov (CEO), John Stuelpnagel (Director), and James Wilbur (Insider). Learn More on 10x Genomics' active insiders.
Are insiders buying or selling shares of 10x Genomics?: During the last year, insiders at the sold shares 26 times. They sold a total of 169,989 shares worth more than $9,072,678.40. The most recent insider tranaction occured on November, 24th when CEO Serge Saxonov sold 3,723 shares worth more than $162,769.56. Insiders at 10x Genomics own 10.7% of the company. Learn More about insider trades at 10x Genomics.
Information on this page was last updated on 11/24/2023.

Serge Saxonov Insider Trading History at 10x Genomics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/24/2023	Sell	3,723	$43.72	$162,769.56	847,446
11/22/2023	Sell	3,757	$43.34	$162,828.38	851,169
10/16/2023	Sell	21	$39.50	$829.50	858,905
9/14/2023	Sell	2,000	$49.37	$98,740.00	862,093
8/22/2023	Sell	3,757	$45.78	$171,995.46	864,093
8/14/2023	Sell	2,000	$50.11	$100,220.00	867,850
7/19/2023	Sell	40,000	$60.03	$2,401,200.00	869,850
7/14/2023	Sell	2,000	$58.05	$116,100.00	889,005
6/14/2023	Sell	2,000	$58.16	$116,320.00	891,005
5/23/2023	Sell	2,602	$55.06	$143,266.12	893,190
5/15/2023	Sell	2,000	$53.35	$106,700.00	895,792
4/14/2023	Sell	2,000	$53.82	$107,640.00	897,792
2/22/2023	Sell	1,941	$47.75	$92,682.75	909,715
11/22/2022	Sell	2,676	$34.07	$91,171.32	974,926
8/23/2022	Sell	2,715	$35.19	$95,540.85	966,102
5/23/2022	Sell	2,656	$48.76	$129,506.56	968,817
2/22/2022	Sell	551	$78.60	$43,308.60
2/8/2022	Sell	12,000	$89.90	$1,078,800.00
1/4/2022	Sell	15,000	$141.33	$2,119,950.00
12/7/2021	Sell	15,000	$145.97	$2,189,550.00
11/22/2021	Sell	772	$148.38	$114,549.36
11/2/2021	Sell	15,000	$161.25	$2,418,750.00
10/5/2021	Sell	15,000	$143.50	$2,152,500.00
9/7/2021	Sell	15,000	$188.42	$2,826,300.00
8/23/2021	Sell	742	$161.85	$120,092.70
7/6/2021	Sell	15,000	$193.08	$2,896,200.00
6/8/2021	Sell	15,000	$186.37	$2,795,550.00	904,068
5/24/2021	Sell	771	$162.66	$125,410.86
5/4/2021	Sell	15,000	$184.08	$2,761,200.00	885,676
4/6/2021	Sell	15,000	$195.81	$2,937,150.00	885,676
2/1/2021	Sell	10,000	$176.00	$1,760,000.00	889,576
1/4/2021	Sell	10,000	$139.93	$1,399,300.00	890,468
12/1/2020	Sell	10,000	$151.40	$1,514,000.00	973,431
11/2/2020	Sell	7,076	$136.35	$964,812.60	973,431
9/1/2020	Sell	10,000	$113.97	$1,139,700.00	955,821
8/3/2020	Sell	10,000	$99.33	$993,300.00	963,181
7/1/2020	Sell	10,000	$87.58	$875,800.00	963,181
6/1/2020	Sell	10,000	$79.82	$798,200.00	963,181
5/1/2020	Sell	10,000	$77.39	$773,900.00	955,514
4/1/2020	Sell	10,000	$58.07	$580,700.00	960,514
3/6/2020	Sell	10,000	$65.14	$651,400.00	946,347

Serge Saxonov Buying and Selling Activity at 10x Genomics

10x Genomics Company Overview

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Today's Range

Now: $48.84

$46.84

$49.20

50 Day Range

MA: $40.45

$34.32

$48.84

2 Week Range

Now: $48.84

$31.28

$63.57

Volume

1,076,706 shs

Average Volume

812,307 shs

Market Capitalization

$5.77 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Invest in Autonomix today.

Serge Saxonov Biography and Net Worth

What is Serge Saxonov's net worth?

How old is Serge Saxonov?

What is Serge Saxonov's salary?

How do I contact Serge Saxonov?

Has Serge Saxonov been buying or selling shares of 10x Genomics?

Who are 10x Genomics' active insiders?

Are insiders buying or selling shares of 10x Genomics?